Sven Rohmann

Directeur Général chez BIO VITOS PHARMA

Profil

Sven Rohmann currently works at Bio Vitos Pharma AB, as Chief Executive Officer from 2025, Hervolution ApS, as Director, Center for Molecular Medicine (Sweden), as Chief Business Development Officer, and Tcer AB, as Chief Business Development Officer.
Dr. Rohmann also formerly worked at Ganymed Pharmaceuticals AG, as Chief Executive Officer, Vivesto AB, as Chief Executive Officer & Director from 2019 to 2020, Biovision AG, as Chief Executive Officer, Mendus AB, as Chief Executive Officer from 2020 to 2021, Adiuvo Investment SA, as Chief Executive Officer, Helix BioPharma Corp., as Chairman in 2017, ImVisioN GmbH, as Chairman, Helix Polska Sp zoo, as Chairman, LifeMD, Inc., as Director & Co-Chief Medical Officer-Global from 2015 to 2017, Burrill LLC, as General Manager-Europe Region, Nextech Invest AG, as General Partner, ArcticZymes Technologies ASA, as Vice President, Pantec Biosolutions AG, as Chief Business Officer, and Novartis Pharma AG, as Fund Manager.
Dr. Rohmann received his doctorate degree from Erasmus University Rotterdam, doctorate degree from The Johannes Gutenberg University of Mainz, and Masters Business Admin degree from Kellogg School of Management.

Postes actifs de Sven Rohmann

Sociétés	Poste	Début
BIO VITOS PHARMA	Directeur Général	01/01/2025
Inprother ApS	Directeur/Membre du Conseil	-
Tcer AB	Corporate Officer/Principal	-
Center for Molecular Medicine (Sweden)	Corporate Officer/Principal	-

Anciens postes connus de Sven Rohmann

Sociétés	Poste	Fin
MENDUS AB	Directeur Général	16/03/2021
HELIX BIOPHARMA CORP.	Directeur Général	31/03/2017
Pantec Biosolutions AG	Corporate Officer/Principal	-
Helix Polska Sp zoo	Président	-
Novartis Pharma AG	Corporate Officer/Principal	-